510(k) Report

FDA applicant

App Pharmaceuticals, LLC

Appollo Beach, FL1 decision2010–20101 recall

FDA records 1 decision for App Pharmaceuticals, LLC (Appollo Beach, FL) in 2010: 1 510(k) clearance. All are in product code NZW (Heparin, Vascular Access Flush). Its devices cite 1 predicate, 0 of them its own earlier devices. 1 recall is linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, general hospital panel, where it files most

How often FDA has decided App Pharmaceuticals, LLC’s devices, and how often a recall has named them.

FDA decisions per year

1in 2010

2010: 1
2010high 1 (2010) · low 0 (2011)2026

2026 so far, outlined.

Recalls per year

1in 2014

2014: 1
2010high 1 (2014) · low 0 (2010)2026

Class I Class II/III not classified

FIG. 1 — App Pharmaceuticals, LLC by year, 2010–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like App Pharmaceuticals, LLC’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Which product codes does it file in?

  • NZWHeparin, Vascular Access Flush1decision

Whose devices does it build on?

Its devices cite 1 predicate; 0 are its own earlier devices. The firms it cites most:

What has FDA decided for it lately?

  • K092938Heparin Lock Flush Solution Usp, Models 504401, 504411, 504505, 505701, 504901, 1710App Pharmaceuticals, LLC · 20101 recall

The one decision as App Pharmaceuticals, LLC →

What has been recalled?

1 recall linked to its devices; the latest:

  • K092938HEPFLUSH-10 (HEPARIN LOCK FLUSH SOLUTION, USP) 100 USP units per 10 mL (10 USP units per…Dec 19, 2014Class II